Key result
Elevated right atrial volume index (HR 1.035) and E/Emtricuspid ratio (HR 1.106) were independent predictors of atrial high-rate episodes in patients with cardiac implantable electronic devices.
Why the study?
Atrial high-rate episodes (AHRE) are linked to clinical AF, thromboembolism, and mortality, but the predictive role of right-heart echocardiographic features needed evaluation.
Do right-heart echocardiographic parameters predict atrial high-rate episodes in patients with CIEDs?
Cohort (n=194)
No
Do right-heart echocardiographic parameters predict atrial high-rate episodes in patients with CIEDs?
Right atrial volume index (RAVI) and E/Em tricuspid ratio are independent echocardiographic predictors of atrial high-rate episodes in patients with cardiac implantable electronic devices.
Answers are grounded in this paper and cite their sources.
Right-heart structure was associated with AHRE; hypothesis-generating and requires prospective validation before clinical use.
Objectives Atrial high-rate episodes (AHRE) defined as atrial tachy-arrhythmias, detected through continuous monitoring with a cardiac implantable electronic device (CIED). AHRE's have been associated with increased risks of developing clinically manifested atrial fibrillation (AF), thromboembolism, cardiovascular events, and mortality. Several variables have been researched and identified to predict AHRE existence. The present study evaluated the association between right-heart structural and functional echocardiographic parameters and AHRE in patients with CIEDs. Materials and Methods This prospective design study included 194 patients with CIED's. The study population was divided into two groups according to presence of AHRE and analyzed the echocardiographic variables which may able to be a predictor of AHRE. Results Patients was divided into two groups: patients with AHRE (+) and without AHRE (-). The distribution of patients’ characteristics according to presence of AHRE was analyzed. The multivariate analysis revealed Age, LAVI, E/Em tricuspid (HR: 1,106, 1,015 − 1,205%95 CI, p = 0,022) and RAVI (HR: 1,035, 1,003 − 1,069 95% CI; p = 0,033) as independent predictors of AHREs. ROC curve analysis indicated that an E/Em tricuspid (AUC: 0,611, 95% CI: 0,538-0,680 p: 0.009) and RAVI (AUC = AUC: 0,707, 95% CI 0,637-0,770 p < 0.001) predicted AHREs with a cut-off value of 6.28 and a sensitivity of 53,2% and specificity of 66,7% and a cut-off value of 29,5 mL/m 2 with a sensitivity of 72,7% and a specificity of 65,9%, respectively. Conclusion The main finding of this study was "RAVI" and "E/Emtricuspid ratio" is associated with AHRE. Additionally, "RAVI" and "E/Emtricuspid ratio" is an independent predictor of AHRE existence.
No takes yet. Share an insight, caveat, or question.
Artaç et al. (2023) conducted a cohort in Cardiovascular implantable electronic devices (CIEDs) (n=194). Right atrial volume index (RAVI) and E/Emtricuspid ratio vs. Lower RAVI and E/Emtricuspid ratio was evaluated on Atrial High-Rate Episodes (AHRE) (HR 1.035, 95% CI 1.003-1.069, p=0.033). Elevated right atrial volume index (HR 1.035) and E/Emtricuspid ratio (HR 1.106) were independent predictors of atrial high-rate episodes in patients with cardiac implantable electronic devices.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: